Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Restoring Endoluminal Narrowing Using Bioresorbable Scaffolds - Extended Trial III

NCT02900937 is registered in ClinicalTrials.gov with Amaranth Medical Inc. as lead sponsor.

NCT NCT02900937
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02900937 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Restoring Endoluminal Narrowing Using Bioresorbable Scaffolds - Extended Trial III
Lead sponsor
Amaranth Medical Inc.
Phase
Phase 2
Overall status
Unknown status
Start date
October 31, 2016
Completion date
June 30, 2022
Enrollment
70 (estimated)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

coronary artery disease, myocardial ischemia